Addus HomeCare Corporation (ADUS) Stock Forecast
ADUS analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.29 / 5 from 14 analysts
- Price target
- $134.08 average of analyst targets
- Upside to target
- +15.6% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $1.61
- 52-week range
- $88.49 – $122.75
ADUS analyst ratings
14 analystsNumber of analysts at each rating.
ADUS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ADUS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.79 | $1.75 | $1.86 | $1.56 | +14.9% | 13 |
| Current fiscal year (2026) | $7.05 | $6.96 | $7.14 | $6.23 | +13.1% | 14 |
| Next fiscal year (2027) | $7.52 | $7.30 | $7.67 | $7.05 | +6.7% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ADUS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $388.7M | $386.4M | $390.4M | +7.3% | 12 |
| Current fiscal year (2026) | $1.52B | $1.51B | $1.53B | +7.1% | 13 |
| Next fiscal year (2027) | $1.60B | $1.58B | $1.62B | +4.8% | 12 |
ADUS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ADUS revenue: reported and forecast
ADUS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.76 | $1.79 | $1.79 | $1.79 | $1.79 | +1.7% | 2 up · 0 down |
| Current fiscal year (2026) | $7.00 | $7.04 | $7.05 | $7.05 | $7.05 | +0.7% | 2 up · 0 down |
| Next fiscal year (2027) | $7.48 | $7.52 | $7.52 | $7.51 | $7.52 | +0.4% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ADUS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ADUS beat in 12 of 12.
What analysts expect from ADUS
14 analysts cover Addus HomeCare; their consensus rating is buy (4.29 on a 1–5 scale, where 5 is a strong buy). The average price target is $134.08, 15.6% above the latest close of $115.98. Analysts expect earnings of $7.05 per share for 2026, +13.1% from a year earlier. For 2027 the average estimate is $7.52 per share on revenue of $1.6 billion. Addus HomeCare beat the EPS estimate in 12 of the last 12 quarters.
Related: ADUS income statement, ADUS key metrics, ADUS chart. See the ADUS stock overview for the latest quote and news.
ADUS forecast FAQ
What is Addus HomeCare's price target?
The average analyst price target for Addus HomeCare is $134.08, 15.6% above the latest close of $115.98.
Is Addus HomeCare a buy, hold or sell?
Of 14 analysts covering Addus HomeCare, 8 rate it a strong buy, 3 a buy, 2 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Addus HomeCare's EPS forecast?
Analysts forecast $7.05 per share for 2026 (range $6.96 to $7.14); for 2027 the estimate is $7.52.
What is Addus HomeCare's revenue forecast?
The average revenue estimate for 2026 is $1.5 billion, growth of 7.1%; for 2027 it is $1.6 billion.
When does Addus HomeCare report earnings?
Addus HomeCare is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $1.61.
Does Addus HomeCare usually beat earnings estimates?
Addus HomeCare reported EPS at or above the analyst estimate in 12 of the last 12 quarters.